The use of plasmapheresis and intravenous laser blood irradiation in treatment of patients with newly diagnosed tuberculosis at the late stages of hiv infection (references review)
- Authors: Polyakov A.A.1, Kornilova Z.H.2, Demikhova O.V.2
-
Affiliations:
- The Tuberculosis Clinical Hospital N11 of Health Department of Moscow
- Central Research Institute of Tuberculosis
- Issue: Vol 25, No 4 (2017)
- Pages: 655-668
- Section: Reviews
- URL: https://bakhtiniada.ru/pavlovj/article/view/7739
- DOI: https://doi.org/10.23888/PAVLOVJ20174655-668
- ID: 7739
Cite item
Abstract
This article presents an overview of the current domestic and foreign literature on the problems of treatment of newly diagnosed tuberculosis in patients with late stages of HIV infection. The urgency of the problem, peculiarities of the clinical course and treatment of tuberculosis, the principles of antiretroviral therapy in the combination of tuberculosis and HIV infection are considered. It has been established that long-term chronic (или “long term” или “chronic”) tuberculosis intoxication, as well as aggressive antituberculosis therapy, lead to disruption of metabolic processes, hypercatabolism, intoxication, and development of hypercoagulable syndrome. At the same time, data is provided on the toxic effects of antiretroviral therapy. Treatment of adverse reactions begins with detoxification and antihistamine therapy followed by the addition of vitamin therapy, antioxidants, antihypoxants, hepatoprotectors, anabolic agents, and enterosorbents. Various methods of pathogenetic therapy are of great interest, including extracorporal hemocorrection (plasmapheresis) and intravenous laser irradiation of blood (ILIB). Plasmapheresis (PA) allows the effective and short time normalization of homeostasis indices as well as reduction or elimination of intoxication effects, toxic and allergic reactions, hence increasing the effectiveness of basic therapy. Course of PA in patients with common forms of tuberculosis (3-5 procedures, with an interval of 2-3 days, removal of 20-25% of the volume of circulating plasma and replacement with crystalloid solutions in combination with hydroxyethyl starches) allows the elimination of symptoms of intoxication, increases tolerance of the organism to chemotherapy, and suppresses undesirable side effects. The method of quantum therapy (ILIB) is based on the effect of quantum energy on blood directly in the vascular bed. As the result photo biological influence of ILIB, all body systems are activated to correct the existing disorders. This is manifested to a great extent in tissues suffering from oxygen deficiency, since it is in these areas the metabolism increases and the processes of tissue reparation are activated. ILID helps for activation of white blood cell function, phagocytosis, synthesis of antibodies, interferon, and in general, improves the immune status.
Full Text
##article.viewOnOriginalSite##About the authors
A. A. Polyakov
The Tuberculosis Clinical Hospital N11 of Health Department of Moscow
Author for correspondence.
Email: aapolyak@bmail.ru
ORCID iD: 0000-0003-1549-1909
Head of Hemosorbtion Department of the Tuberculosis Hospital N11 of Health Department of Moscow
Russian Federation, Rabukhina str., 7, 141504, Moscow region, SolnechnogorskZ. H. Kornilova
Central Research Institute of Tuberculosis
Email: kajukovalnp@gmail.com
Russian Federation, Yauzskaya Аlley, 2, 107564, Moscow
O. V. Demikhova
Central Research Institute of Tuberculosis
Email: demikhova@mail.ru
ORCID iD: 0000-0002-3843-9911
SPIN-code: 9461-8730
MD, Grand PhD, Professor, Director for Scientific Work of the Central Scientific Research Institute of Tuberculosis
Russian Federation, Yauzskaya Аlley, 2, 107564, MoscowReferences
- Situacija po VICh-infekcii v Ros-sijskoj Federacii za 2015 g.: spravka. Moscow: Federal'nogo Centra monitoringa proti-vodejstvija rasprostraneniju tuberkuleza; 2016. (In Russ).
- VICh-infekcija: informacionnyj bjulleten' №38. Moscow: Federal'nyj nauchno-metodicheskij centr po profilaktike i bor'be so SPIDom; 2013. (In Russ).
- Frolova OP, Polesskij VA, Novose-lova OA, et al. Tuberkulez u bol'nyh s VICh-infekciej kak nacional'naja problema. Tuber-kulez i bolezni legkih. 2013;10:9-12. (In Russ).
- Tuberkulez: informacionnyj bjulleten'. Geneva: WHO; 2017. Available at: http://docs.spbmiac.ru/docs/materialy-voz/2017-god/informacionnyi-byulleten-za-noyabr. Accessed: 29.09.2017. (In Russ).
- Tursunov RA. Model' razvitija jepidemii VICh-infekcii v Respublike Tad-zhikistan vo vtorom desjatiletii XXI veka. Rossijskiy mediko-biologicheskiy vestnik imeni akademika I.P. Pavlova. 2016;24(1):35-40. (In Russ).
- Nacional'nye klinicheskie rekomenda-cii po diagnostike i lecheniju VICh-nfekcii u vzroslyh. Мoscow; 2014. (In Russ).
- Bartlet D, Redfild R, Fam P, et al. Klinicheskie aspekty VICh-infekcii. Moscow: R. Valent; 2013. (In Russ).
- Popova AA, Kravchenko AV, Kozhevnikova GM, et al. Znachenie dinamiki CD8+CD28+ i CD4+CD28+ u bol'nyh VICh-infekciej v sochetanii s tuberkulezom v processe lechenija. Terapevticheskij Arhiv. 2013;11:54-7. (In Russ).
- Pozniak AL, Coyne KM, Miller RF, et al. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011. HIV Medicine. 2011;12: 517-24.
- Trailescu AM, Apti G. Clinical and radiological features of tuberculosis in HIV patients. AMT. 2012;11:142-8.
- Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries; 2013. Available at: http://www.pih.ru/docs/PIH_MSF_MDR_Guidelines.pdf. Accessed: 29.09.2017.
- Dannye po VICh / SPID 15 stran Vostochnoj Evropy i Central'noj Azii. East Europe–Central Asia Union of PLWH. 2011. Available at: http://ecuo.org/for_about/ About_mission_goal/Listovka_A4_rus_final.pdf. Accessed: 29.09.2017. (In Russ).
- Management of tuberculosis and HIV coinfection: Clinical Protocol for the WHO European Region; 2013. Available at: http://www.euro.who.int/__data/assets/pdf_file/0004/218515/Management-of-tuberculosis-and-HIV-coinfection-Eng.pdf. Accessed: 29.09.2017.
- Adapting WHO normative HIV guidelines for national programmes; 2011. Available at: http://www.aidsdatahub.org/ sites/default/files/documents/Adapting_WHO_normative_HIV_guidelines_for_national_programmes.pdf. Accessed: 29.09.2017.
- Principi N, Esposito S. Diagnosis and therapy of tuberculous meningitis in children. Tuberculosis. 2012;92:377-383.
- Federal'nye klinicheskie rekomenda-cii po diagnostike i lecheniju tuberkuleza u bol'nyh VICh-infekciej. Mosсow; 2016. Avai-lable at: http://roftb.ru/netcat_files/doks2016/ rec2016.pdf. Accessed: 29.09.2017. (In Russ).
- Antiretroviral treatment as prevention (TASP) of HIV and TB. Geneva: WHO; 2012.
- The South African Antiretroviral Treatment Guidelines; 2013. Available at: http://www.kznhealth.gov.za/medicine/2013_ART_Guidelines.pdf. Accessed: 29.09.2017.
- Bekker LG, Wood R. TB and HIV co-infection: When to start antiretorviral therapy. South Africa Medical Journal. 2011;29(10):420-6.
- Pepper DJ, Marais S, Wilkinson RJ, et al. Barriers to initiation of antiret-rovirals during antituberculosis therapy. South Africa Medical Journal. 2012;102(12):936-9. doi: 10.1371/journal.pone.0019484.
- Kaminskaja GO, Abdullaev RJu, Serebrjanaja BA, et al. Uchastie sistemy ge-mostaza v formirovanii sindroma sistemnogo vospalitel'nogo otveta u bol'nyh tuberkulezom legkih. Tuberkulez i bolezni legkih. 2011; 2:52-8. (In Russ).
- Kaminskaja GO, Abdullaev RJu, Ko-misarova OG. Sostojanie belkovogo obmena kak faktor nespecificheskoj reaktivnosti organizma bol'nyh tuberkulezom legkih. Tuberkulez i bolezni legkih. 2012;12:30-5. (In Russ).
- Balasanjanc GS, Suhanov DS, Ajzikov DL. Pobochnye jeffekty protivotuber-kuleznyh preparatov i metody ih ustranenija: Uchebnoe posobie. 2nd ed. Saint Petersburg: Taktik-Studio; 2011. (In Russ).
- Hoffman K, Rokshtro JuK. Lechenie VICh-infekcii. Moscow: R. Valent; 2012. (In Russ).
- Rukovodstvo po primeneniju antiretrovirusnyh preparatov u vzroslyh i podrostkov, inficirovannyh VICh-1. Moscow; 2011. Available at: https://arvt.ru/sites/ default/files/DHHS_Guidelines_2011_RUS.pdf. Accessed: 29.09.2017. (In Russ).
- Joshi D, O’Grady J, Dieterich D. Increasing burden of liver disease in patients with HIV infection. Lancet. 2011;377:1198-1209.
- Alskauskas ZC, Medapalli RK, Ross MJ. Expert opinion on pharmacotherapy of kidney diseases in HIV-infected patients. Expert Opinion Pharmacotherapy. 2011; 12:691-704.
- Titjuhina MV. Jeffektivnost' kompleksnogo lechenija bol'nyh tuberkulezom razlichnoj lokalizacii pri primenenii jefferentnyh metodov detoksikacii i nutritivnoj podderzhki dissertation. Moscow; 2012. (In Russ).
- Shojhet JaN, Roshhev IP, Syzdykbaev MK. Jeffektivnost' primenenija plazmafereza s vozmeshheniem plazmopoteri kriosupernatantnoj frakciej plazmy u bol'nyh s gnojno-destruktivnymi zabolevanijami legkih. Sibirskij medicinskij zhurnal. 2012; 27(4):55-60. (In Russ).
- Guidelines for Therapeutic Plasma Exchange. Beaumont: Beaumont Hospital; 2013. Available at: http://www.beaumont.ie/ files/2010/docs/20111017035250_Plasma_guideline%20final.pdf. Accessed: 30.09.2017.
- Sablin I.D, Dorofeyev EE. Expe-rience of application of therapeutic plasma-pheresis in a patient with antenatal fetal death in combination with isoniazid poisoning. International virtual conference. 2012. Available at: http://www.arsa-conf.com. Accessed: 30.09.2017.
- Komissarova OG. Osobennosti te-chenija processa i jeffektivnost' lechenija u M.J. bol'nyh lekarstvenno-ustojchivym tuber-kulezom legkih pri razlichnoj intensivnosti sindroma sistemnogo vospalitel'nogo otveta dissertation. Moscow; 2011. (In Russ).
- Markina VM. Kliniko-immunolo-gicheskaja jeffektivnost' ul'trafioletovogo obluchenija krovi s gipohloritom natrija v kompleksnom lechenii bol'nyh HOBL dissertation. Kursk; 2011. (In Russ).
- Urjas'ev UM, Isaeva IA. Ocenka jeffektivnosti primenenija vnutrivennoj laze-roterapii i preryvistoj normobaricheskoj gipo-ksiterapii v kompleksnom lechenii bron-hial'noj astmy s soputstvujushhej gipertoni-cheskoj bolezn'ju. Rossijskiy mediko-bio-logicheskiy vestnik imeni akademika I.P. Pavlova. 2014;22(2):113-7. (In Russ).
- Fukumoto R, Burns TM, Kiang JG. Ciprofloxacin enhances stresserythropoiesis in spleen and increases survival after whole-body irradiation combined with skin-wound trauma. PLoS. 2014;9(2):904-8.
- Dogorova O, Pavlova E, Vinokurova M. Regional Lymphotropic Therapy for Treating Multi-Drug-Resistant Tuberculosis. International Journal of Biomedicine. 2016;6(1):82-4.
- Shprykov AS, Sutjagina DA. Himiolazeroterapija bol'nyh infil'trativnym tuberkulezom legkih opredelenie citokino-vogo statusa, blizhajshie i otdalennye rezul'-taty lechenija. STM. 2011;4:162-4. (In Russ).
- Hanin AL, Pil'nik GV, Nikotina GL. Rezul'taty primenenija infrakrasnoj lazernoj terapii v kompleksnom lechenii bol'nyh s vpervye vyjavlennym destruktivnym tuber-kulezom legkih. Vestnik sovremennoj klini-cheskoj mediciny. 2015;8(3):40-4. (In Russ).
- Xu J, Xiang L, Chen J, et al. The combination treatment using CO laser and photodynamic therapy for HIV seropositive men with intraanal warts. Photodiagnosis Photodynamic Therapy. 2013;10(2):186-93.
Supplementary files
